We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 8,538 results
  1. Estimating conditional vaccine effectiveness

    Vaccine effectiveness for COVID-19 is typically estimated for different outcomes that often are hierarchical in severity (e.g. any documented...

    John P. A. Ioannidis in European Journal of Epidemiology
    Article 26 September 2022
  2. Conditional versus non-conditional incentives to maximise return of participant completed questionnaires in clinical trials: a cluster randomised study within a trial

    Background

    High participant retention enhances the validity of clinical trials. A monetary incentive can increase retention, but it is not known if...

    Johanna Cook, Jonathan A. Cook, ... Chris C. Butler in Trials
    Article Open access 07 November 2023
  3. Conditional Funding Recommendations for Drugs in Canada: A Cross-Sectional Analysis

    Background and Objective

    Before listing by drug plans, new drugs that receive regulatory bodies’ approval are assessed by the Health Technology...

    Article 07 January 2023
  4. The formation mechanism of primary health care team effectiveness : a qualitative comparative analysis research

    Background

    Team-based care is an essential part of primary health care (PHC), and its team service delivery process is a systematic one involving...

    Chanjiao Li, Lu Cui, ... Ziling Ni in BMC Primary Care
    Article Open access 29 January 2024
  5. HTA Barriers for Conditional Approval Drugs

    Background

    Conditional approval pathways facilitate accelerated marketing authorisation based on immature clinical evidence for drugs that address an...

    Mackenzie Mills in PharmacoEconomics
    Article 23 February 2023
  6. Effectiveness of conditional cash transfers, subsidized child care and life skills training on adolescent mothers’ schooling, sexual and reproductive health, and mental health outcomes in Burkina Faso and Malawi: the PROMOTE Project pilot randomized controlled trial protocol

    Introduction

    Girls’ and women’s health as well as social and economic wellbeing are often negatively impacted by early childbearing. In many parts of...

    Caroline W. Kabiru, Alister Munthali, ... Witness Olex Tapani Alfonso in Reproductive Health
    Article Open access 09 November 2023
  7. Vaccine effectiveness against emerging COVID-19 variants using digital health data

    Background

    Participatory surveillance of self-reported symptoms and vaccination status can be used to supplement traditional public health...

    Tanner J. Varrelman, Benjamin Rader, ... John S. Brownstein in Communications Medicine
    Article Open access 06 May 2024
  8. Cost-effectiveness and feasibility of conditional economic incentives and motivational interviewing to improve HIV health outcomes of adolescents living with HIV in Anambra State, Nigeria

    Background

    In sub-Saharan Africa, there is increasing mortality and morbidity of adolescents due to poor linkage, retention in HIV care and adherence...

    Obinna Ikechukwu Ekwunife, Chinelo Janefrances Ofomata, ... George Uchenna Eleje in BMC Health Services Research
    Article Open access 11 July 2021
  9. Estimating sensitivity and specificity of diagnostic tests using latent class models that account for conditional dependence between tests: a simulation study

    Background

    Latent class models are increasingly used to estimate the sensitivity and specificity of diagnostic tests in the absence of a gold...

    Suzanne H. Keddie, Oliver Baerenbold, ... John Bradley in BMC Medical Research Methodology
    Article Open access 10 March 2023
  10. Cost-effectiveness of differentiated care models that incorporate economic strengthening for HIV antiretroviral therapy adherence: a systematic review

    Background

    There is some evidence that differentiated service delivery (DSD) models, which use a client-centered approach to simplify and increase...

    Annie Liang, Marta Wilson-Barthes, Omar Galárraga in Cost Effectiveness and Resource Allocation
    Article Open access 24 May 2024
  11. Conditional survival analysis and dynamic survival prediction for intracranial solitary-fibrous tumor/hemangiopericytoma

    Background

    As the form of World Health Organization Central Nervous System (WHO CNS) tumor classifications is updated, there is a lack of research on...

    Dagang Song, Zhihao Yang, ... Zhiwei Gu in Journal of Cancer Research and Clinical Oncology
    Article Open access 28 February 2024
  12. The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial

    Background

    In contrast to evidence for interventions supporting victim/survivors of domestic violence and abuse (DVA), the effectiveness of...

    Karen Morgan, Mei-See Man, ... Helen Cramer in Trials
    Article Open access 28 September 2023
  13. Transporting Comparative Effectiveness Evidence Between Countries: Considerations for Health Technology Assessments

    Internal validity is often the primary concern for health technology assessment agencies when assessing comparative effectiveness evidence. However,...

    Alex J. Turner, Cormac Sammon, ... Joshua Ray in PharmacoEconomics
    Article Open access 27 October 2023
  14. Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts

    Background

    Although COVID-19 vaccines and their booster regimens protect against symptomatic infections and severe outcomes, there is limited evidence...

    Ting Zeng, Yaoqin Lu, ... Shi Zhao in Respiratory Research
    Article Open access 12 October 2023
  15. Rudi Kundini, Pamoja Kundini (RKPK): study protocol for a hybrid type 1 randomized effectiveness-implementation trial using data science and economic incentive strategies to strengthen the continuity of care among people living with HIV in Tanzania

    Background

    Economic incentives can improve clinical outcomes among in-care people living with HIV (PLHIV), but evidence is limited for their...

    Jillian L. Kadota, Laura J. Packel, ... Sandra I. McCoy in Trials
    Article Open access 10 February 2024
  16. Cost-effectiveness of TB diagnostic technologies in Ethiopia: a modelling study

    Background

    Tuberculosis (TB) is a major threat to public health, particularly in countries where the disease is highly prevalent, such as Ethiopia....

    Lelisa Fekadu Assebe, Andargachew Kumsa Erena, ... Boshen Jiao in Cost Effectiveness and Resource Allocation
    Article Open access 21 May 2024
  17. Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany

    Background and Objective

    Haemophilia B is a rare genetic disease that is caused by a deficiency of coagulation factor IX (FIX) in the blood and leads...

    Niklaus Meier, Hendrik Fuchs, ... Matthias Schwenkglenks in PharmacoEconomics - Open
    Article Open access 23 March 2024
  18. Utilizing an artificial intelligence framework (conditional generative adversarial network) to enhance telemedicine strategies for cancer pain management

    Background

    The utilization of artificial intelligence (AI) in healthcare has significant potential to revolutionize the delivery of medical services,...

    Marco Cascella, Giuliana Scarpati, ... Sergio Coluccia in Journal of Anesthesia, Analgesia and Critical Care
    Article Open access 20 June 2023
  19. ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requiring a PASS would be more likely to be reimbursed in Spain

    Background

    The present study aims to assess clinical and regulatory variables that would influence pricing and reimbursement (P&R) decisions for...

    José Luis Poveda, Claudia Gómez, ... Xavier Badia in Orphanet Journal of Rare Diseases
    Article Open access 06 January 2023
  20. Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study

    Introduction

    Effectiveness and respiratory adverse events following coronavirus disease-2019 (COVID-19) vaccines have not been well investigated in...

    Simon **wen Qin, Franco Wing Tak Cheng, ... Esther Wai Yin Chan in Drug Safety
    Article Open access 12 December 2023
Did you find what you were looking for? Share feedback.